2015 New Frontiers in the US Point-of-Care/POC Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is VPGMarketResearchs new report, which provides comprehensive analysis of theten POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
- Review of theten POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts for over 300 chemistry,
immunodiagnostic, microbiology, hematology and coagulation procedures by market
- Home/Personal Testing
- Physician Offices/Group Practices
- Emergency Rooms
- Operating/Recovery Suites
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers
and by test category:
- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Flow Cytometry
- Drugs of Abuse
- Endocrine Function
- Tumor Markers
Sales and Market Share Analysis
- Sales and market shares ofmajor reagent and instrument suppliers.
Current and Emerging Tests and Instrumentation
- Analysis of over 130 diagnostic procedures.
- Review of leading chemistry, immunoassay, hematology and coagulation analyzers market by
Abaxis, Abbott, Alfa Wasserman, Awareness Technologies, Beckman Coulter/Danaher, Becton Dickinson, Behnk Elektronik, Biocode, Bio/Data, bioMerieux, Cardiovascular Diagnostics, Carolina Chemistries, Diagnostica Stago, Diesse Ves Matic, Drew-Scientific, Helena Laboratories, Horiba, Instrumentation Laboratory, Inverness, ITC Hemochron, Medica, Menarini, Nihon Kohden, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Sysmex, Teco Medical Instruments, Trinity Biotech, and other suppliers.
Routine Clinical Chemistry Tests
Infectious Disease Tests
ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,
Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,
Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,
Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,
Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,
Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,
Tissue Polypeptide Antigen, and others.
Routine and Special Hematology Tests
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual) ,
Hemoglobin (Automated, Manual) , Sedimentation Rate, Reticulocytes, WBC (Automated, Manual) ,
Platelets (Automated, Manual) , Bone Marrow Analysis, RBC, Eosinophils and others.
Flow Cytometry Tests
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others) , Chemotherapy Monitoring (Leukemia/Lymphoma, Others) , HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.
Endocrine Function Tests
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,
Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.
Therapeutic Drug Monitoring (TDM) Tests
Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate,
Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin,
Valproic Acid, Vancomycin.
Activated Clotting Time (ACT) (1) , Activated Protein C Resistance,
Activated PTT (APTT) , Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,
Factor Ixa, Factor X (Stuart Factor) , Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT) , Reptilase Time, Thrombin Time,
Von Willebrand`s Factor Fav/Ag, and others.
C3, C4, CRP, IgA, IgE Soecific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis,
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,
LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.
- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing POC diagnostic technologies
and products, by test.
- Specific opportunities for new POC instruments and reagent systems with potentially
significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
- Assessments of major suppliers and emerging market entrants, including their sales, product
portfolios, marketing tactics, joint ventures, and new products in R&D.
- The companies analyzed in the report include:
- ADI/American Diagnostica
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Decode Genetics
- Diagnostica Stago/Trinity Biotech
- Eiken Chemical
- EKF Diagnostics
- Helena Laboratories
- Instrumentation Laboratory
- International Technidyne/Nexus DX
- Kyowa Medex
- Mackay Life Sciences
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Takara Bio
- ThermoFisher/Life Technologies
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group`s proprietary data files.
Contains 1,172 pages and256 tables
SIMILAR MARKET STUDIES
Nucleic Acid Testing: Infectious Diseases, Cancer, Genetic Diseases, Forensic Testing, Paternity Testing/HLA Typing--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
"This unique seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. strong Highlight Business and technological trends in seven major markets Five and ten-year test volume and sales forecasts Market shares of ...
June 2014 | $15900 | View Details >>
?New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape? is Venture Planning Group?s new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Japan; reviews current and emerging assays; ...
May 2014 | $21100 | View Details >>
This new 340-page report from VPGMarketResearch.com contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and ...
May 2016 | $0 | View Details >>
The report presents a detailed analysis of the Enterovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Enterovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market ...
February 2017 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research